Abstract
Inflammation is a critical biological response to injury or infection, but chronic inflammation is linked to numerous diseases, including cardiovascular disorders, diabetes, and autoimmune diseases. The development of anti-inflammatory drugs has been pivotal in mitigating the harmful effects of inflammation. Recent advances in the field of anti-inflammatory drug research have focused on novel therapeutic agents, including biologics, small molecule inhibitors, and natural compounds with fewer side effects and higher efficacy. This article reviews the current state of anti-inflammatory drug development, with an emphasis on the mechanisms of action, recent breakthroughs, and future directions in the treatment of inflammatory diseases.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.